Abbott Laboratories (ABT) Shares Outstanding (Diluted Average) (2009 - 2026)

Abbott Laboratories' Shares Outstanding (Diluted Average) history runs 18 years deep, the most recent figure standing at $1.7 billion for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) changed 0.01% year-over-year to $1.7 billion; the TTM figure through Mar 2026 stood at $1.7 billion (changed 0.01% YoY), while the FY2025 annual figure was $1.7 billion, changed 0.0% from the prior year.
• Shares Outstanding (Diluted Average) came in at $1.7 billion for Q1 2026 at Abbott Laboratories, roughly flat from $1.7 billion in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $1.8 billion in Q1 2022 to a low of $1.7 billion in Q1 2026.
• A 5-year average of $1.8 billion and a median of $1.7 billion in 2025 frame the typical range for Shares Outstanding (Diluted Average).
• Across the five-year window, Shares Outstanding (Diluted Average) declined 1.55% in 2022 and gained 0.09% in 2025, its largest moves.
• Abbott Laboratories' Shares Outstanding (Diluted Average) stood at $1.8 billion in 2022, then fell by 0.85% to $1.7 billion in 2023, then declined by 0.06% to $1.7 billion in 2024, then changed by 0.0% to $1.7 billion in 2025, then decreased by 0.05% to $1.7 billion in 2026.
• According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $1.7 billion, $1.7 billion, and $1.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison